Ula Maniewski-Kelner

Medicine & Life Sciences

1. Post-Exposure Prophylaxis 100%
2. Schistosoma haematobium 94%
3. Schistosoma 92%
4. Belgium 89%
5. Cutaneous Leishmaniasis 83%
6. Refugees 82%
7. Campylobacter 81%
8. Dengue 79%
9. Rabies 79%
10. Schistosomiasis 77%
11. Erythromycin 72%
12. Ciprofloxacin 71%
13. South Africa 69%
14. Routine Diagnostic Tests 66%
15. Antibody Formation 61%
16. meropenem 61%
17. Disease Outbreaks 60%
18. Immunoglobulins 59%
19. Anti-Bacterial Agents 54%
20. Fever 54%
21. Retrospective Studies 52%
22. Cross-Sectional Studies 52%
23. Polymerase Chain Reaction 50%
24. Antibodies 46%
25. Antigens 44%
26. Eosinophils 44%
27. Enzyme-Linked Immunosorbent Assay 42%
28. Tropical Medicine 40%
29. Amoxicillin-Potassium Clavulanate Combination 35%
30. Urine 32%
31. Praziquantel 29%
32. Fresh Water 22%
33. Serum 22%
34. Mitochondrial DNA 22%
35. Ovum 20%
36. Protozoan Infections 19%
37. Syria 19%
38. Microscopy 19%
39. Campylobacter Infections 19%
40. Mediterranean Region 18%
41. Therapeutics 18%
42. Tetracyclines 17%
43. Parasitic Diseases 16%
44. Leishmaniasis 16%
45. Confidence Intervals 16%
46. Leishmania 15%
47. Severe Dengue 15%
48. Fluoroquinolones 15%
49. Macrolides 15%
50. Microbial Drug Resistance 14%